Asset Details
Do you wish to reserve the book?
Update on Barriers to Pharmacotherapy for Opioid Use Disorders
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Update on Barriers to Pharmacotherapy for Opioid Use Disorders
Do you wish to request the book?
Update on Barriers to Pharmacotherapy for Opioid Use Disorders
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Update on Barriers to Pharmacotherapy for Opioid Use Disorders
2017
Overview
Purpose of Review
The recent heroin and prescription opioid misuse epidemic has led to a sharp increase in the number of opioid overdose deaths in the USA. Notwithstanding the availability of three FDA-approved medications (methadone, buprenorphine, and naltrexone) to treat opioid use disorder, these medications are underutilized. This paper provides an update from the recent peer-reviewed literature on barriers to the use of these medications.
Findings
These barriers are interrelated and can be categorized as financial, regulatory, geographic, attitudinal, and logistic. While financial barriers are common to all three medications, other barriers are medication-specific.
Summary
The adverse impact of the current opioid epidemic on public health can be reduced by increasing access to effective pharmacotherapy for opioid use disorder.
Publisher
Springer US,Springer Nature B.V
Subject
Analgesics, Opioid - therapeutic use
/ Buprenorphine - therapeutic use
/ Health Services Accessibility
/ Humans
/ Medicine
/ Naltrexone - therapeutic use
/ Narcotic Antagonists - therapeutic use
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - prevention & control
/ Substance Use and Related Disorders (F Levin and E Dakwar
